Therapeutic landscape of Rad51 in cancer treatment (IMAGE)

FAR Publishing Limited

Therapeutic landscape of Rad51 in cancer treatment

Caption

Therapeutic landscape of Rad51 in cancer treatment. Key elements include (1) DNA damage sources (PARPi, chemo/radiotherapy);(2) repair pathways (Rad51‐mediated HR); (3) intervention strategies (Rad51 inhibitors, CRISPR/Cas9); and (4) combination approaches(immunotherapy).

 

Credit

Zhendong Qin，Mingjun Lu ，Jingwei Guo ，Chenyang Wang ，Teng Ma

Usage Restrictions

None

License

Original content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.